An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India.
Sign Up to like & getrecommendations! Published in 2021 at "PLoS neglected tropical diseases"
DOI: 10.1371/journal.pntd.0009069
Abstract: BACKGROUND Better drug regimens for mass drug administration (MDA) could accelerate the Global Programme to Eliminate Lymphatic Filariasis (LF). This community study was designed to compare the safety and efficacy of MDA with IDA (ivermectin,… read more here.
Keywords: diethylcarbamazine plus; diethylcarbamazine; community study; plus albendazole ... See more keywords